blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2846844

EP2846844 - RADIO-PHARMACEUTICAL COMPLEXES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  28.02.2020
FormerGrant of patent is intended
Status updated on  10.10.2019
FormerExamination is in progress
Status updated on  09.11.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Bayer AS
Drammensveien 288
0283 Oslo / NO
[2016/11]
Former [2016/02]For all designated states
Bayer AS
Postboks 54 Kjelsås
0411 Oslo / NO
Former [2015/12]For all designated states
Algeta ASA
Kjelsåsveien 172A
0884 Oslo / NO
Inventor(s)01 / BONGE-HANSEN, Hanne Therese
c/o Algeta ASA
Kjelsåsveien 172A
0884 Oslo / NO
02 / RYAN, Olav Benjamin
c/o Algeta ASA
Kjelsåsveien 172A
0884 Oslo / NO
 [2015/12]
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[N/P]
Former [2020/14]BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 10
40789 Monheim am Rhein / DE
Former [2015/12]Goddard, Christopher Robert
Dehns
St Bride's House
10 Salisbury Square
London
EC4Y 8JD / GB
Application number, filing date13725586.513.05.2013
[2020/14]
WO2013EP59841
Priority number, dateGB2012000830911.05.2012         Original published format: GB 201208309
[2015/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013167756
Date:14.11.2013
Language:EN
[2013/46]
Type: A1 Application with search report 
No.:EP2846844
Date:18.03.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.2013 takes the place of the publication of the European patent application.
[2015/12]
Type: B1 Patent specification 
No.:EP2846844
Date:01.04.2020
Language:EN
[2020/14]
Search report(s)International search report - published on:EP14.11.2013
ClassificationIPC:A61K51/04, A61K51/10, A61P35/00, A61K103/40
[2015/12]
CPC:
A61K51/0478 (EP,US); A61K51/0474 (US); A61K51/0455 (US);
A61K51/1027 (EP,US); A61K51/1093 (EP,US); A61P35/00 (EP);
A61P35/02 (EP); C07K16/32 (US); A61K2039/505 (US);
C07K2317/24 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/12]
Extension statesBA10.12.2014
ME10.12.2014
TitleGerman:RADIOPHARMAZEUTISCHE KOMPLEXE[2015/12]
English:RADIO-PHARMACEUTICAL COMPLEXES[2015/12]
French:COMPLEXES RADIOPHARMACEUTIQUES[2015/12]
Entry into regional phase10.12.2014National basic fee paid 
10.12.2014Designation fee(s) paid 
10.12.2014Examination fee paid 
Examination procedure10.12.2014Examination requested  [2015/12]
22.06.2015Amendment by applicant (claims and/or description)
08.11.2018Despatch of a communication from the examining division (Time limit: M06)
08.05.2019Reply to a communication from the examining division
27.05.2019Despatch of a communication from the examining division (Time limit: M01)
26.06.2019Reply to a communication from the examining division
11.10.2019Communication of intention to grant the patent
20.02.2020Fee for grant paid
20.02.2020Fee for publishing/printing paid
20.02.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.11.2018
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Fees paidRenewal fee
12.05.2015Renewal fee patent year 03
10.05.2016Renewal fee patent year 04
10.05.2017Renewal fee patent year 05
11.05.2018Renewal fee patent year 06
15.05.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.05.2013
AL01.04.2020
AT01.04.2020
CY01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
MK01.04.2020
MT01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
TR01.04.2020
IE13.05.2020
LU13.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
[2022/32]
Former [2022/27]HU13.05.2013
AL01.04.2020
AT01.04.2020
CY01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
MT01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
TR01.04.2020
IE13.05.2020
LU13.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2022/26]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
TR01.04.2020
IE13.05.2020
LU13.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/24]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SI01.04.2020
SK01.04.2020
SM01.04.2020
IE13.05.2020
LU13.05.2020
BE31.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/20]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SK01.04.2020
SM01.04.2020
IE13.05.2020
LU13.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/15]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SK01.04.2020
SM01.04.2020
LU13.05.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/10]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
PL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SK01.04.2020
SM01.04.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/09]AL01.04.2020
AT01.04.2020
CZ01.04.2020
DK01.04.2020
EE01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
IT01.04.2020
LT01.04.2020
LV01.04.2020
MC01.04.2020
NL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SM01.04.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/08]AL01.04.2020
CZ01.04.2020
DK01.04.2020
ES01.04.2020
FI01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
NL01.04.2020
RO01.04.2020
RS01.04.2020
SE01.04.2020
SM01.04.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/07]AL01.04.2020
CZ01.04.2020
DK01.04.2020
FI01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
NL01.04.2020
RS01.04.2020
SE01.04.2020
CH31.05.2020
LI31.05.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2021/04]AL01.04.2020
CZ01.04.2020
FI01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
NL01.04.2020
RS01.04.2020
SE01.04.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2020/51]CZ01.04.2020
FI01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
NL01.04.2020
RS01.04.2020
SE01.04.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2020/50]CZ01.04.2020
FI01.04.2020
HR01.04.2020
LT01.04.2020
LV01.04.2020
NL01.04.2020
SE01.04.2020
BG01.07.2020
NO01.07.2020
GR02.07.2020
IS01.08.2020
PT17.08.2020
Former [2020/49]CZ01.04.2020
FI01.04.2020
LT01.04.2020
NL01.04.2020
SE01.04.2020
BG01.07.2020
NO01.07.2020
IS01.08.2020
PT17.08.2020
Former [2020/48]FI01.04.2020
LT01.04.2020
NL01.04.2020
SE01.04.2020
BG01.07.2020
NO01.07.2020
IS01.08.2020
PT17.08.2020
Former [2020/47]LT01.04.2020
BG01.07.2020
NO01.07.2020
IS01.08.2020
Former [2020/46]BG01.07.2020
IS01.08.2020
Former [2020/39]BG01.07.2020
Cited inInternational search[Y]WO2006003123  (EUROPEAN COMMUNITY [BE], et al) [Y] 1-27 * page 7, lines 24-27 * * page 10, lines 20-28 ** page 11, line 20 - page 12, line 12 *;
 [Y]WO2008085064  (GE HEALTHCARE AS [NO], et al) [Y] 1-27 * page 3, line 15 - page 4, line 3 * * examples 4-10,12,13,17 *;
 [YD]WO2011098611  (ALGETA AS [NO], et al) [YD] 1-27 * page 4, 5th full paragraph to page 5, 1st full paragraph * * page 15, 3rd full paragraph to page 16, line 1 * * page 16, 3rd full paragraph to page 17, 3rd full paragraph * * page 25, line 4 to page 26, line 3 and formulae V, VI and VII * * examples 2, 8 *
by applicantUS5624901
 WO0160417
 WO0205859
 WO2004091668
 WO2008063721
 WO2011098611
    - FEINENDEGEN ET AL., RADIAT RES, (1997), vol. 148, pages 195 - 201
    - WILBUR, ANTIBODY IMMUNOCON RADIOPHARM, (1991), vol. 4, pages 85 - 96
    - LARSEN, J NUCL MED, (2002), vol. 43, no. 5, page 160P
    - MUIIER, INT. J. RADIAT. BIOL., (1971), vol. 20, pages 233 - 243
    - GORDON AEV ET AL., "Rational design of sequestering agents for plutonium and other actinides", CHEM. REV., (2003), vol. 103, doi:doi:10.1021/CR990114X, pages 4207 - 4282, XP002639641

DOI:   http://dx.doi.org/10.1021/CR990114X
    - T.N. LAMBERT ET AL., TETRAHEDRON LETTERS, (2002), vol. 43, pages 7379 - 7383
    - LEUNG; GOLDENBERG; DION; PELLEGRINI; SHEVITZ; SHIH; HANSEN, MOLECULAR IMMUNOLOGY, (1995), vol. 32, pages 1413 - 27
    - TOLMACHEV; ORLOVA; PEHRSON; GALLI; BAASTRUP; ANDERSSON; SANDSTR6M; ROSIK; CARLSSON; LUNDQVIST, "Radionuclide therapy of HER2-positive microxenografts using a 177Lu-Labeled HER2-specific Affibody molecule", CANCER RES., (2007), vol. 67, doi:doi:10.1158/0008-5472.CAN-06-1630, pages 2773 - 82, XP002488609

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-06-1630
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.